Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Waldenstrom macroglobulinemia, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Recruiting	Phase 2	2026-05-05		NCT05099471

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AbbVie	340
Christian Buske	5
Ludwig-Maximilians - University of Munich	67
Pfizer	431
University Hospital Schleswig-Holstein	49
University of Ulm	46
Zentrum für Klinische Studien Ulm	4

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Alexandra Hospital	Athens	Greece	5
Christliches Klinikum Paderborn, Brüderkrankenhaus St. Josef Paderborn	Paderborn	Germany	1
Dr. Vehling-Kaiser MVZ GmbH	Landshut	Germany	2
Gemeinschaftsklinikum Mittelrhein gGmbH	Koblenz	Germany	1
Haematologie und Onkologie Muenchen-Pasing MVZ GmbH	München	Germany	1
Kliniken Maria Hilf GmbH Moenchengladbach	Mönchengladbach	Germany	1
Kliniken Ostalb, Standort Stauferklinikum Schwäbisch Gmünd	Mutlangen	Germany	1
Klinikum Chemnitz gGmbH	Chemnitz	Germany	32
Klinikverbund Allgaeu gGmbH	Kempten	Germany	1
Onkologische Schwerpunktpraxis Bielefeld	Bielefeld	Germany	5
Universitaet Muenster	Münster	Germany	2
Universitaetsklinikum Schleswig-Holstein AöR	Kiel	Germany	4
University Hospital Ulm	Ulm	Germany	17
Universitätsmedizin Rostock	Rostock	Germany	9